Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.
The universal screening for osteoporosis by bone mineral density (BMD) is not feasible because of its unfavorable cost-benefit due to its low sensitivity. The aim of the present study was to estimate the population and economic impact of the diagnostic criteria of the National Osteoporosis Guideline Group (NOGG) and the National Osteoporosis Foundation (NOF) and assess the appropriateness of the BMD tests performed in routine clinical practice. A cross-sectional study was conducted in individuals referred for BMD testing who were not receiving antiresorptive therapy. The absolute risk of major and hip fracture was calculated using the British formula of the Fracture Risk Assessment Tool. NOGG and NOF guidelines diagnostic thresholds interventions were used. A total of 640 individuals were included, of which 95% were women, with a median age of 59.4 years (interquartile range = 14). When applying the NOGG criteria, BMD testing was recommended in 32.3% of the individuals, whereas this percentage increased to 75.6% with the NOF guidelines (p < 0.05). Regarding the appropriateness of the BMD tests performed, 31.9% were deemed appropriate according to both the NOGG and NOF guidelines, whereas 23.9% were considered inappropriate. In conclusion, the application of the NOGG and NOF guidelines led to a decrease in BMD indications, reducing costs and improving efficiency in the diagnostic management of osteoporosis, although variability exists between the guidelines.
Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, León, Spain. Electronic address: giorgos6@yahoo.com.
Georgios
G
Kyriakos
Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, León, Spain.
Alfonso
A
Vidal-Casariego
Department of Pharmacology, Institute of Biomedicine (IBIOMED), University of León, León, Spain.
María Nélida
MN
Fernández-Martínez
Department of Radiology, Complejo Asistencial Universitario de León, León, Spain.
María Dolores
MD
Blanco-Suárez
Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, León, Spain.
María D
MD
Ballesteros-Pomar
Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, León, Spain.
Isidoro
I
Cano-Rodríguez
D000368:Aged; D015519:Bone Density; D003362:Cost-Benefit Analysis; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000175:diagnosis*; D017410:Practice Guidelines as Topic
Bone density; FRAX; NOF; NOGG; osteoporosis